UBS Group’s AGAPE ATP ATPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24 Sell
8
-2,582
-100% -$7.4K ﹤0.01% 10256
2026
Q1
$6.81K Buy
+2,590
New +$8.26K ﹤0.01% 8650
2025
Q4
Sell
-165
Closed -$10.5K 10488
2025
Q3
$10.5K Sell
165
-413
-71% -$27.5K ﹤0.01% 8539
2025
Q2
$38.2K Buy
578
+505
+692% +$43.5K ﹤0.01% 7997
2025
Q1
$4.7K Sell
73
-1,315
-95% -$78.2K ﹤0.01% 9077
2024
Q4
$81.9K Buy
1,388
+937
+208% +$71.8K ﹤0.01% 6995
2024
Q3
$44K Buy
451
+430
+2,048% +$54.7K ﹤0.01% 6902
2024
Q2
$4.51K Buy
21
+17
+425% +$4.3K ﹤0.01% 8084
2024
Q1
$1.22K Buy
+4
New +$1.79K ﹤0.01% 8189

Other funds holding ATPC

UBS Group's ATPC Position: Q2 2026 in Review

UBS Group reduced its AGAPE ATP (ATPC) stake by 100% in Q2 2026, selling an estimated $7.4K and leaving 8 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #10256.

UBS Group first reported a position in ATPC in Q1 2024 and has held it in 9 quarters since. The position peaked at $81.9K in Q4 2024. 3 funds tracked by Wall St. Rank hold ATPC as of Q2 2026.

  • UBS Group held 8 shares of AGAPE ATP worth $24 as of Q2 2026.
  • UBS Group sold 2,582 AGAPE ATP shares in Q2 2026, an estimated $7.4K.
  • AGAPE ATP made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10256 holding.
  • UBS Group first reported a position in AGAPE ATP in Q1 2024 and has held it in 9 quarters since.
  • UBS Group's AGAPE ATP position peaked at $81.9K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held AGAPE ATP as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.